Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 9,760 | 9,970 | 7,800 | 6,485 | 5,972 |
| Operating Income | -9,760 | -9,970 | -7,800 | -6,485 | -5,972 |
| Other Income | 223 | 233 | 74 | 53 | 36 |
| Pre-tax Income | -9,537 | -9,737 | -7,726 | -6,432 | -5,936 |
| Net Income Continuous | -9,537 | -9,737 | -7,726 | -6,432 | -5,936 |
| Net Income | $-9,537 | $-9,737 | $-7,726 | $-6,432 | $-5,936 |
| EPS Basic Total Ops | -1.07 | -1.19 | -0.94 | -0.79 | -0.73 |
| EPS Basic Continuous Ops | -1.07 | -1.19 | -0.95 | -0.79 | -0.73 |
| EPS Diluted Total Ops | -1.07 | -1.19 | -0.94 | -0.79 | -0.73 |
| EPS Diluted Continuous Ops | -1.07 | -1.19 | -0.95 | -0.79 | -0.73 |
| EPS Diluted Before Non-Recurring Items | -1.07 | -1.19 | -0.38 | -0.93 | N/A |
| EBITDA(a) | $-9,760 | $-9,970 | $-7,800 | $-6,485 | $-5,972 |